3,000,000 SHARES OF FOREST LABORATORIES, COMMON STOCK OFFERED AT $36-5/8 PER SHARE
3,000,000 SHARES OF FOREST LABORATORIES,
COMMON STOCK OFFERED AT $36-5/8 PER SHARE
NEW YORK, Feb. 12 /PRNewswire/ -- Forest Laboratories, Inc. (AMEX: FRX), an international pharmaceutical manufacturer and marketer, announced today that an underwriting group led by Lehman Brothers, Donaldson Lufkin & Jenrette Securities Corporation and Morgan Stanley & Co. Incorporated is offering 3,000,000 shares of common stock by the company and selling shareholders to the public at a price of $36-5/8 per share.
Net proceeds to the company from the sale of the 1,515,000 shares by the company will be used for working capital and general corporate purposes.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy. The common stock is offered for sale by the underwriters solely pursuant to the Prospectus, a copy of which may be obtained from the Prospectus Department of Lehman Brothers, 250 West Street, New York, N.Y. 10013.
/CONTACT: Kenneth E. Goodman, vice president-finance of Forest Laboratories, 212-421-7850/
(FRX) CO: Forest Laboratories Inc. ST: New York IN: MTC SU: OFR SH -- NY024 -- 9123 02/12/92 09:52 EST